In this study cohort of 253 women, 213 had BRCA1 variants and only 40 had BRCA2 variants, which affects the generalizability as BRCA1 is associated with a higher risk of both breast and ovarian cancer. The gene discussed is BRCA1; the disease is ovarian cancer.